Cargando…
Autoimmune Hemolytic Anemia as Presenting Symptom of Hodgkin Lymphoma
Autoimmune hemolytic anemia (AIHA) is related to an underlying condition in an estimated 50 to 60%, while the remaining is idiopathic, as a result of a combination of immune activation, deficiency, or dysregulation. AIHA is associated with viral infections, autoimmune disorders, immunodeficiencies,...
Autores principales: | Burley, Nicholas B., Dy, Paul S., Hande, Suraj, Kalantri, Shreyas, Mohindroo, Chirayu, Miller, Kenneth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026303/ https://www.ncbi.nlm.nih.gov/pubmed/33859850 http://dx.doi.org/10.1155/2021/5580823 |
Ejemplares similares
-
Use of Rituximab in Autoimmune Hemolytic Anemia Associated with Non-Hodgkin Lymphomas
por: Fozza, Claudio, et al.
Publicado: (2011) -
Autoimmune Hemolytic Anemia in a Patient with Primary Ovarian Non-Hodgkin's Lymphoma
por: Jung, Chang Kil, et al.
Publicado: (2004) -
Autoimmune Hemolytic Anemia and Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Rare Association
por: Salmeron, Géraldine, et al.
Publicado: (2013) -
Autoimmune Hemolytic Anemia and Hodgkin's Disease: An Unusual Pediatric Association
por: Gomes, Maria Miguel, et al.
Publicado: (2016) -
Aortic Thrombosis and Acute Limb Ischemia Secondary to COVID Hypercoagulability
por: Burley, Nicholas B, et al.
Publicado: (2021)